Parker William H, Qu Zhi-Chao, May James M
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-0475, USA.
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-0475, USA.
Biochem Biophys Res Commun. 2015 Mar 6;458(2):262-7. doi: 10.1016/j.bbrc.2015.01.096. Epub 2015 Jan 31.
Intracellular vitamin C, or ascorbic acid, has been shown to prevent the apoptosis of cultured vascular pericytes under simulated diabetic conditions. We sought to determine the mechanism by which ascorbate is transported into pericytes prior to exerting this protective effect. Measuring intracellular ascorbate, we found that pericytes display a linear uptake over 30 min and an apparent transport Km of 21 μM, both of which are consistent with activity of the Sodium-dependent Vitamin C Transporter 2 (SVCT2). Uptake of both radiolabeled and unlabeled ascorbate was prevented by inhibiting SVCT2 activity, but not by inhibiting the activity of GLUT-type glucose transporters, which import dehydroascorbate to also generate intracellular ascorbate. Likewise, uptake of dehydroascorbate was prevented with the inhibition of GLUTs, but not by inhibiting the SVCT2, indicating substrate specificity of both transporters. Finally, presence of the SVCT2 in pericytes was confirmed by western blot analysis, and immunocytochemistry was used to localize it to the plasma membrane and intracellular sites. Together, these data clarify previous inconsistencies in the literature, implicate SVCT2 as the pericyte ascorbate transporter, and show that pericytes are capable of concentrating intracellular ascorbate against a gradient in an energy- and sodium-dependent fashion.
细胞内维生素C,即抗坏血酸,已被证明可在模拟糖尿病条件下防止培养的血管周细胞凋亡。我们试图确定抗坏血酸盐在发挥这种保护作用之前转运至周细胞的机制。通过测量细胞内抗坏血酸,我们发现周细胞在30分钟内呈现线性摄取,表观转运Km为21μM,这两者均与钠依赖性维生素C转运蛋白2(SVCT2)的活性一致。抑制SVCT2活性可阻止放射性标记和未标记的抗坏血酸摄取,但抑制GLUT型葡萄糖转运蛋白的活性则不能,后者可导入脱氢抗坏血酸以生成细胞内抗坏血酸。同样,抑制GLUTs可阻止脱氢抗坏血酸的摄取,但抑制SVCT2则不能,这表明两种转运蛋白均具有底物特异性。最后,通过蛋白质印迹分析证实了周细胞中存在SVCT2,并使用免疫细胞化学将其定位到质膜和细胞内位点。总之,这些数据澄清了文献中先前的不一致之处,表明SVCT2是周细胞抗坏血酸转运蛋白,并表明周细胞能够以能量和钠依赖性方式逆浓度梯度浓缩细胞内抗坏血酸。